Gayatri Balan, Bellevue, WA (US); Mark J. Bartlett, Castro Valley, CA (US); Jayaraman Chandrasekhar, Redmond, WA (US); Julian A. Codelli, Seattle, WA (US); John H. Conway, Somerville, MA (US); Jennifer L Cosman, Foster City, CA (US); Rao V. Kalla, Cupertino, CA (US); Zachary A. Kasun, Seattle, WA (US); Musong Kim, Bellevue, WA (US); Seung H. Lee, Sammamish, WA (US); Jennifer R. Lo, Seattle, WA (US); Jennifer A. Loyer-Drew, Seattle, WA (US); Scott A. Mitchell, Kenmore, WA (US); Thao D. Perry, San Jose, CA (US); Gary B. Phillips, Issaquah, WA (US); Patrick J. Salvo, Burien, WA (US); Sundaramoorthi Swaminathan, Burlingame, CA (US); Joshua J. Van Veldhuizen, Seattle, WA (US); Suet C Yeung, Redmond, WA (US); and Jeff Zablocki, Los Altos, CA (US)
Assigned to Gilead Sciences, Inc., Foster City, CA (US)
Filed by Gilead Sciences, Inc., Foster City, CA (US)
Filed on Nov. 9, 2021, as Appl. No. 17/522,628.
Application 17/522,628 is a continuation of application No. 16/669,346, filed on Oct. 30, 2019, granted, now 11,203,591.
Claims priority of provisional application 62/868,550, filed on Jun. 28, 2019.
Claims priority of provisional application 62/753,339, filed on Oct. 31, 2018.
Prior Publication US 2022/0213091 A1, Jul. 7, 2022
